Preservation of collagen-induced whole blood platelet aggregation by tranexamic acid therapy in primary cardiac valve surgery

Abstract

Haemostatic disorder is one of the most common complications following cardiac surgery with cardiopulmonary bypass (CPB). Tranexamic acid reduces blood loss and allogeneic blood transfusion requirement in cardiac surgery. It had been thought that tranexamic acid inhibited fibrinolysis alone following CPB.

In the present study, the haemostatic effects of tranexamic acid (20 mg/kg body weight bolus after induction of anaesthesia followed by continuous infusion at 2 mg/kg/h), including fibrinolysis and platelet function, were investigated in 22 patients (tranexamic acid group n = 12; control group n = 10) undergoing primary cardiac valve surgery.

Fibrinolysis following CPB was reduced significantly in the tranexamic acid group. Following protamine administration, the reduction of collagen-induced whole blood platelet aggregation was mitigated significantly in the tranexamic acid group compared with the control group (36% reduction in the tranexamic acid group vs 58% in the control group; p = 0.011), although platelet counts did not differ between the two groups.

In conclusion, tranexamic acid not only inhibits fibrinolysis directly, but also may preserve platelet function following CPB.

Get full access to this article

View all access options for this article.

References

Horrow JC. Management of coaglopathy associated with cardiopulmonary bypass. In: Gravlee GP , David RF , Ultey JR eds. Cardiopulmonary bypass: principles and practice. Baltimore, MD: Williams & Wilkins , 1993: 436-466.

Campbell FW , Edmunds H. Platelet function and cardiopulmonary bypass. In: Gravlee GP , David RF , Ultey JR eds. Cardiopulmonary bypass: principles and practice. Baltimore, MD: Williams & Wilkins , 1993: 407-435.

Edmunds H , Ellison N , Colman RW et al. Platelet function during cardiac operation . J Thorac Cardiovasc Surg 1982; 83: 805-812 .

Ray MJ , Marsh NA , Hawson AT. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass . Blood Coag Fibrinol 1994; 5: 679-685 .

Blauhut B , Harringer W , Bettelheim P , Doran JE , Spath P , Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass . J Thorac Cardiovasc Surg 1994; 108: 1083-1091 .

Royston D , Bidstrup BP , Taylor KM , Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open heart surgery . Lancet 1987; 2: 1289-1291 .

Menichetti A , Tritapepe L , Ruvalo G et al. Changes in coaglation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid . J Cardiovasc Surg 1996; 37: 401-407 .

van Oeveren W , Harder MP , Roozendaal KJ , Eijsman L , Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass . J Thorac Cardiovasc Surg 1990; 99: 788-797 .

Lu H , Soria C , Commin PL et al. Haemostasis in patients indergoing extracorporeal circulation: The effect of aprotinin (Trasylol) . Thromb Haemost 1991; 66: 633-637 .

10.

DelRossi AJ , Cernaianu AC , Vertrees RA et al. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass . J Thorac Cardiovasc Surg 1990; 100: 281-286 .

11.

Hardy JF , Belisle S , Dupont C et al. Prophylactic tranexamic acid and ε-aminocaproic acid for primary myacardial revascularization . Ann Thorac Surg 1998; 65: 371-376 .

12.

Brown RS , Thwaites BK , Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial . Anesth Analg 1997; 85: 963-970 .

13.

Mongan PD , Brown RS , Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization . Anesth Analg 1998; 87: 258-265 .

14.

Adelman B , Michelson AD , Greenberg J , Handin RI. Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions . Blood 1986; 68: 1280-1284 .

15.

Stricker RB. Wong D. Shiu DT. Reyes PT. Shuman MA. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation . Blood 1986; 68: 275-280 .

16.

Guffin AV , Dunbar RW , Kaplan JA et al. Successful use of a reduced dose of protamine after cardiopulmonary bypass . Anesth Analg 1976; 55: 110-113 .

17.

Plotz FB , van Oeveren W , Aloe LS et al. Prophylatic administration of tranexamic acid preserves platelet numbers during extracorporeal circulation in rabbit . ASAIO Trans 1991; 37: 416-417 .

18.

Saslau G , Horrow JC , Brodski I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation . Am J Hematol 1991; 38: 113-119 .

19.

Menzies SA , Hartley JA , Hitchcock ER , Rorke E , Gill JS. The effect of tranexamic acid on bleeding time and hemostasis . Neurochirurgia 1991; 34; 141-143 .

20.

Dietrich W , Spath P , Ebell A , Ritcher JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred and forty-eight re-exposures to aprotinin in heart operations . J Thorac Cardiovasc Surg 1997; 113: 194-201 .